ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,856Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 122

$803K Total Retail Price of All Prescriptions

Rank: 4 out of 122

452 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

8% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 11,265 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
FUROSEMIDE 681 585 1 5
SIMVASTATIN 446 394 2 1
WARFARIN SODIUM 439 361 3 9
LISINOPRIL 398 352 4 2
LEVOTHYROXINE SODIUM 368 306 5 4
OMEPRAZOLE 301 259 6 3
TRAZODONE HCL 297 249 7 21
AMLODIPINE BESYLATE 269 234 8 7
METOPROLOL TARTRATE 263 233 9 8
CITALOPRAM HBR 253 190 10 15
ATORVASTATIN CALCIUM 237 220 11 13
TRAMADOL HCL 232 198 12 20
FENTANYL 222 182 S2 13 47
SERTRALINE HCL 196 187 14 18
DONEPEZIL HCL 187 166 15 25
METFORMIN HCL 184 147 16 14
GABAPENTIN 167 140 17 12
ZOLPIDEM TARTRATE 167 136 17 19
LANTUS 161 140 19 36
RISPERIDONE 159 143 20 64
HYDROCODONE-ACETAMINOPHEN 151 90 S3 21 16
HYDROCHLOROTHIAZIDE 139 124 22 6
ATENOLOL 138 118 23 10
POTASSIUM CHLORIDE 131 123 24 22
CARVEDILOL 120 112 25 56
LOSARTAN POTASSIUM 108 84 26 17
FAMOTIDINE 107 94 27 58
METOPROLOL SUCCINATE 106 88 28 11
GLIPIZIDE 103 92 29 77
ACTOS 102 79 30 92
LOSARTAN-HYDROCHLOROTHIAZIDE 101 84 31 55
VENLAFAXINE HCL ER 98 42 32 54
POLYETHYLENE GLYCOL 3350 98 76 32 75
MORPHINE SULFATE ER 97 60 S2 34 42
TAMSULOSIN HCL 95 80 35 26
NAMENDA 94 74 36 65
IPRATROPIUM-ALBUTEROL 93 86 37 99
ISOSORBIDE MONONITRATE ER 92 76 38 44
ESCITALOPRAM OXALATE 91 79 39 59
JANTOVEN 89 87 40 100
MIRTAZAPINE 86 71 41 61
LEVOFLOXACIN 85 79 42 80
QUETIAPINE FUMARATE 83 71 43 46
CYMBALTA 82 40 44 62
JANUVIA 81 61 45 78
CARBIDOPA-LEVODOPA 81 75 45 79
NYSTOP 78 70 47 144
BACLOFEN 74 56 48 119
MORPHINE SULFATE 70 50 S2 49 111
CLOPIDOGREL 66 50 50 45
NOVOLOG 66 57 50 115
NEXIUM 66 38 50 32
PANTOPRAZOLE SODIUM 65 55 53 23
PROAIR HFA 64 51 54 31
CELEBREX 64 54 54 52
OLANZAPINE 63 55 56 153
ADVAIR DISKUS 61 51 57 34
SPIRIVA 60 55 58 29
OXYBUTYNIN CHLORIDE 58 43 59 107
TRANSDERM-SCOP 58 24 59 158
PAROXETINE HCL 57 43 61 69
TRIAMCINOLONE ACETONIDE 57 35 61 83
ALLOPURINOL 57 51 61 33
CRESTOR 54 37 64 37
DILTIAZEM 24HR ER 53 52 65 108
DILTIAZEM 24HR CD 53 49 65 66
CYCLOBENZAPRINE HCL 52 22 R 67 93
NOVOLIN R 52 49 67 168
LEVETIRACETAM 52 52 67 133
CEPHALEXIN 50 50 70 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.